Hepatosplenic candidiasis in the era of new antifungal drugs: A study in Paris 2000-2007

Clinical Microbiology and Infection

Volumn 18, Issue 6, 2012, Pages

  De Castro, N ^a   Mazoyer, E ^a   Porcher, R ^a   Raffoux, E ^a,d   Suarez, F ^b   Ribaud, P ^a,d   Lortholary, O ^b,c   Molina, J M ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c INSTITUT PASTEUR   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Candida; Hepatosplenic candidiasis; Liver; Prognostic factors

Indexed keywords

ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; POLYENE; POSACONAZOLE; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDIASIS; CHILD; CLINICAL ARTICLE; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; FRANCE; FUNGAL COLONIZATION; HEMATOLOGIC MALIGNANCY; HEPATOSPLENIC CANDIDIASIS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER HISTOLOGY; MALE; NEUTROPENIA; POSITRON EMISSION TOMOGRAPHY; POST TREATMENT SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT DURATION; TREATMENT RESPONSE;

CANDIDA;

EID: 84860994198     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2012.03819.x     Document Type: Article

References (20)

1. Masood A, Sallah S. Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment. Leuk Res 2005; 29: 493-501.
2. Sallah S, Wan JY, Nguyen NP, Vos P, Sigounas G. Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting: a follow-up study. Cancer 2001; 92: 1349-1353.
3. Chen C-Y, Chen Y-C, Tang J-L et al. Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment, and prognosis. Ann Hematol 2003; 82: 93-97.
4. Pagano L, Mele L, Fianchi L et al. Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes. Haematologica 2002; 87: 535-541.
5. Rossetti F, Brawner DL, Bowden R et al. Fungal liver infection in marrow transplant recipients: prevalence at autopsy, predisposing factors, and clinical features. Clin Infect Dis 1995; 20: 801-811.
6. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
7. Kontoyiannis DP, Luna MA, Samuels BI, Bodey GP. Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis. Infect Dis Clin North Am 2000; 14: 721-739.
8. Anttila VJ, Elonen E, Nordling S, Sivonen A, Ruutu T, Ruutu P. Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clin Infect Dis 1997; 24: 375-380.
9. Alam FF, Mustafa AS, Khan ZU. Comparative evaluation of (1, 3)-β-d-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect Dis 2007; 7: 103.
10. Sallah S, Semelka RC, Wehbie R, Sallah W, Nguyen NP, Vos P. Hepatosplenic candidiasis in patients with acute leukaemia. Br J Haematol 1999; 106: 697-701.
11. Kontoyiannis DP, Reddy BT, Torres HA et al. Pulmonary candidiasis in patients with cancer: an autopsy study. Clin Infect Dis 2002; 34: 400-403.
12. Cornely OA, Maertens J, Winston DJ et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007; 356: 348-359.
13. Nihtinen A, Anttila V-J, Elonen E, Juvonen E, Volin L, Ruutu T. Effect of fluconazole prophylaxis on the incidence of invasive Candida infections and bacteraemias in patients with acute leukaemia. Eur J Haematol 2008; 80: 391-396.
14. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-535.
15. Anaissie E, Bodey GP, Kantarjian H et al. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. Am J Med 1991; 91: 142-150.
16. Kauffman CA, Bradley SF, Ross SC, Weber DR. Hepatosplenic candidiasis: successful treatment with fluconazole. Am J Med 1991; 91: 137-141.
17. Cheng VC, Yuen KY, Wong SS et al. Immunorestitution diseases in patients not infected with HIV. Eur J Clin Microbiol Infect Dis 2001; 20: 402-406.
18. Legrand F, Lecuit M, Dupont B et al. Adjuvant corticosteroid therapy for chronic disseminated candidiasis. Clin Infect Dis 2008; 46: 696-702.
19. 18F]fluorodeoxyglucose for invasive fungal infections. Clin Microbiol Infect 2011; 17: 409-417.
20. Walter RB, Kantarjian HM, Huang X et al. Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study. J Clin Oncol 2010; 28: 1766-1771.